US FDA Commissioner Califf’s Farewell Visit To Capitol Hill

 
• By Michael McCaughan

Robert Califf’s final appearance on Capitol Hill as US FDA commissioner, a 5 December Senate hearing focused on the agency’s food and nutrition functions, was an appropriate coda to his tenure and preview of things to come under the Trump Administration.

Califf and baby formula
The infant formula shortage food safety a larger part of Commissioner Robert Califf's focus after he took over the agency in 2022. • Source: Nielsen Hobbs; the Pink Sheet | Alamy and Shutterstock images
Michael McCaughan

Read more by Michael McCaughan

Michael McCaughan is a founding member of Prevision Policy LLC, a leading provider of regulatory and reimbursement policy analysis for the biopharma industry. He was previously the Editor-In-Chief of The Pink Sheet and remains a contributor to the publication.

More from US FDA

More from Legislation